Skip to main content
Victor Prieto, MD, Pathology, Houston, TX, University of Texas M.D. Anderson Cancer Center

VictorG.PrietoMDPhD

Pathology Houston, TX

Dermatopathology, Anatomic Pathology, Surgical Pathology

Full Professor

Dr. Prieto is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Prieto's full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Dermatopathology, 1995 - 1996
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 1991 - 1994
  • Universidad Central de Barcelona
    Universidad Central de BarcelonaPhD, Cellular Biology, PhD cum laude, 1989 - 1991
  • Other
    OtherClass of 1986, MD

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2001 - 2024
  • NC State Medical License
    NC State Medical License 1996 - 2006
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Dermatopathology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2006-2014
  • Top Doctors:SE Texas Castle Connolly, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
    Scott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
  • Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
    Janice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
  • Melanoma Coexisting with Solar Elastosis: A Potential Pitfall in the Differential Diagnosis Between Nevus and Melanoma  
    Michael T Tetzlaff, Victor G Prieto, Phyu P Aung, Priyadharsini Nagarajan, ScienceDirect
  • Join now to see all

Press Mentions

  • Pembrolizumab Trial in Advanced Melanoma Shows Major Pathological Response Exceeding 50%
    Pembrolizumab Trial in Advanced Melanoma Shows Major Pathological Response Exceeding 50%October 25th, 2023
  • Major Pathologic Response to Neoadjuvant Pembrolizumab in Advanced Melanoma Trial Exceeds 50%
    Major Pathologic Response to Neoadjuvant Pembrolizumab in Advanced Melanoma Trial Exceeds 50%October 25th, 2023

Hospital Affiliations